— Know what they know.
Not Investment Advice

Financial News

Sentiment -53.9 5216 articles 2591 bullish 1469 bearish Full Index →
Head-To-Head Contrast: Ralliant (NYSE:RAL) & Senseonics Hold

Head-To-Head Contrast: Ralliant (NYSE:RAL) & Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)

Ralliant (NYSE:RAL – Get Free Report) and Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) are both manufacturing...
AdaptHealth (NASDAQ:AHCO) Trading Up 8.3% on Insider Buying

AdaptHealth (NASDAQ:AHCO) Trading Up 8.3% on Insider Buying Activity

AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report)’s stock price was up 8.3% during trading on Tuesday following insider buying activity....
Orthofix Medical Inc. (NASDAQ:OFIX) Receives Average Rating

Orthofix Medical Inc. (NASDAQ:OFIX) Receives Average Rating of “Hold” from Brokerages

Orthofix Medical Inc. (NASDAQ:OFIX – Get Free Report) has received a consensus recommendation of “Hold” from the six research firms...
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus R

Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Buy” from Analysts

Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) has been given a consensus rating of “Buy” by the thirteen analysts that...
GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recomm

GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine...
Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of

Veracyte, Inc. (NASDAQ:VCYT) Given Average Recommendation of “Hold” by Brokerages

Veracyte, Inc. (NASDAQ:VCYT – Get Free Report) has earned a consensus rating of “Hold” from the eight analysts that are covering...
Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve...
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation

aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of “Hold” by Analysts

aTyr Pharma, Inc. (NASDAQ:ATYR – Get Free Report) has been given a consensus recommendation of “Hold” by the seven research firms...
Short Interest in NexGel, Inc. (NASDAQ:NXGL) Expands By 4,75

Short Interest in NexGel, Inc. (NASDAQ:NXGL) Expands By 4,758.2%

NexGel, Inc. (NASDAQ:NXGL – Get Free Report) was the recipient of a large increase in short interest in the month of March. As of March 13th,...
Adagio Medical (NASDAQ:ADGM) Trading Up 11.5%  – Time to Buy

Adagio Medical (NASDAQ:ADGM) Trading Up 11.5% – Time to Buy?

Adagio Medical Holdings, Inc. (NASDAQ:ADGM – Get Free Report)’s share price traded up 11.5% during mid-day trading on Tuesday . The stock...
Biotricity (NASDAQ:BTCY) Trading Down 1.4%  – Time to Sell?

Biotricity (NASDAQ:BTCY) Trading Down 1.4% – Time to Sell?

Biotricity, Inc. (NASDAQ:BTCY – Get Free Report) dropped 1.4% during trading on Tuesday . The company traded as low as $0.2282 and last traded...
Scilex (NASDAQ:SCLX) Stock Price Down 10.1%  – Here’s What H

Scilex (NASDAQ:SCLX) Stock Price Down 10.1% – Here’s What Happened

Shares of Scilex Holding Company (NASDAQ:SCLX – Get Free Report) were down 10.1% on Tuesday . The stock traded as low as $6.60 and last traded...
📰

Novo Nordisk A/S: Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo...
Ralliant (NYSE:RAL) versus Senseonics Holdings, Inc. Common

Ralliant (NYSE:RAL) versus Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Critical Review

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) and Ralliant (NYSE:RAL – Get Free Report) are both manufacturing...
Zacks Research Forecasts Editas Medicine FY2028 Earnings

Zacks Research Forecasts Editas Medicine FY2028 Earnings

Editas Medicine, Inc. (NASDAQ:EDIT – Free Report) – Research analysts at Zacks Research issued their FY2028 earnings per share estimates...
Ultragenyx Pharmaceutical (NASDAQ:RARE) Reaches New 1-Year L

Ultragenyx Pharmaceutical (NASDAQ:RARE) Reaches New 1-Year Low on Analyst Downgrade

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report)’s stock price reached a new 52-week low on Tuesday after The Goldman Sachs...
Achieve Life Sciences Sees Unusually Large Options Volume (N

Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV)

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Free Report) was the target of unusually large options trading activity on Tuesday. Stock...
Alvotech (NASDAQ:ALVO) Sets New 12-Month Low After Analyst D

Alvotech (NASDAQ:ALVO) Sets New 12-Month Low After Analyst Downgrade

Shares of Alvotech (NASDAQ:ALVO – Get Free Report) reached a new 52-week low on Wednesday after UBS Group lowered their price target on the...
RemeGen Co., Ltd. (OTCMKTS:REGMF) Short Interest Update

RemeGen Co., Ltd. (OTCMKTS:REGMF) Short Interest Update

RemeGen Co., Ltd. (OTCMKTS:REGMF – Get Free Report) saw a significant increase in short interest in March. As of March 13th, there was short...
Eaton Vance Ultra-Short Income ETF (NYSEARCA:EVSB) Short Int

Eaton Vance Ultra-Short Income ETF (NYSEARCA:EVSB) Short Interest Up 45,976.0% in March

Eaton Vance Ultra-Short Income ETF (NYSEARCA:EVSB – Get Free Report) was the target of a large growth in short interest during the month of...
Palantir  And Palmer Luckey's Anduril Team Up On Trump's $18

Palantir And Palmer Luckey's Anduril Team Up On Trump's $185 Billion Golden Dome Missile Shield: Report

Anduril Industries and Palantir Technologies (NASDAQ:PLTR) are reportedly collaborating on software for Donald Trump's ambitious $185 billion...
Ralliant (NYSE:RAL) & Senseonics Holdings, Inc. Common Stock

Ralliant (NYSE:RAL) & Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Head to Head Comparison

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS – Get Free Report) and Ralliant (NYSE:RAL – Get Free Report) are both manufacturing...
SAFE Structure Designs Delivers Custom Aviation Maintenance

SAFE Structure Designs Delivers Custom Aviation Maintenance Tooling for U.S. Army's CH-47 Chinook Block II Fleet

www.SAFE-2.com LAS VEGAS, March 25, 2026 /PRNewswire/ -- SAFE Structure Designs, an American defense engineering and manufacturing company...
Elizabeth Warren Questions Nvidia's $20 Billion Groq Move: '

Elizabeth Warren Questions Nvidia's $20 Billion Groq Move: 'Is This Deal An Attempt To Avoid Antitrust Scrutiny?'

On Tuesday, Sen. Elizabeth Warren (D-Mass.) took to X to question whether Nvidia Corp (NASDAQ:NVDA) has effectively acquired Groq without triggering...
Blaize Holdings Is Trending As Stock Shoots Up 49% Overnight

Blaize Holdings Is Trending As Stock Shoots Up 49% Overnight: Here's Why

Blaize Holdings Inc. (NASDAQ:BZAI) shares are trending on Tuesday night. Shares of the California-based AI platform company rose 48.65% after hours...
GIGABYTE AORUS geht eine Partnerschaft mit VALORANT Esports

GIGABYTE AORUS geht eine Partnerschaft mit VALORANT Esports EMEA ein

GIGABYTE AORUS wird die VALORANT Champions Tour EMEA und die Game Changers EMEA in den Spielzeiten 2026 und 2027 als Sponsor unterstützen. Das...
📰

Ultragenyx Pharmaceutical Inc. Notice of April 6, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

NEW YORK and NEW ORLEANS, March 24, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of...
📰

AIxCrypto Holdings Reports Full Year 2025 Financial Results; Highlights Transformational Pivot to AI and Blockchain Infrastructure

LOS ANGELES, March 24, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ:AIXC, or the &#34, Company&#34, )), today reported financial results for...
📰

AIxCrypto Holdings Reports Full Year 2025 Financial Results; Highlights Transformational Pivot to AI and Blockchain Infrastructure

LOS ANGELES, March 24, 2026 /PRNewswire/ -- AIxCrypto Holdings, Inc. (NASDAQ: AIXC, or the "Company"), today reported financial results for the...
📰

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company...
📰

A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story

Bausch + Lomb, a global leader in eye health products and surgical devices, reported a recent insider buy amid ongoing sector activity.
📰

INO DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. Investors to Secure Counsel Before Important April 7 Deadline in Securities Class Action – INO

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Bragar Eagel & Squire, P.C. Urges Picard Medical, Inc. (NYSE:PMI) Investors to Contact the Firm Before April 3rd Regarding Their Rights

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Picard (PMI) To Contact Him Directly To...
📰

Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest trading session, Teladoc (TDOC) closed at $5.42, marking a -1.09% move from the previous day.
📰

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aardvark Therapeutics, Inc. - AARD

<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /> <p...
📰

Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know

Boston Scientific (BSX) concluded the recent trading session at $68.15, signifying a -2% move from its prior day's close.
📰

CORT DEADLINE NOTICE: Corcept Therapeutics Incorporated Investors Encouraged to Contact Kirby McInerney LLP By April 21, 2026

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- If you suffered a loss on your investment in Corcept Therapeutics Incorporated ("Corcept" or the...
« Prev 1 32 33 34 35 36 81 Next »

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms